About this trial
This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.
Eligibility criteria
Qualifiers
Age 18-30
Current weekly user of e-cigarette product(s) for the last 30 days
Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent)
Experience downloading and using one or more apps on their smartphone
Disqualifiers
Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatment is allowable during trial participation)
Member of the same household as another research participant
Currently in prison
Google voice number as sole phone number, due to its association with fraudulent study entry attempts
Trial design
Treatments tested in this trial
- Smartphone app
- Smartphone app
- Text Message
- Text Message
- Survey Administration
Treatment groups
Sponsors and collaborators
Fred Hutchinson Cancer Center
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator